Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gaétan Guillemette

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Cattle
Rats

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
49
Escher, Emanuel
39
Leduc, Richard
19
Boulay, Guylain
15
Bernier, SG
12
Lavigne, Pierre
11
Servant, Guy
11
Poitras, M
10
Laporte, Stephane
9
Boucard, Antony
9
Auger-Messier, Mannix
8
Chrétien, L
8
Leclerc, Patrice
8
Richard, DE
7
Sirois, Pierre
7
Caron, Annabelle

Sign-in to see all Coauthors

Publications

TOP 3
Domazet Ivana; Martin Stéphane S; Holleran Brian J; Morin Marie-Eve; Lacasse Patrick; Lavigne Pierre; Escher Emanuel; Leduc Richard; Guillemette Gaétan
The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.
Clément Martin; Cabana Jérôme; Holleran Brian J; Leduc Richard; Guillemette Gaétan; Lavigne Pierre; Escher Emanuel
Activation induces structural changes in the liganded angiotensin II type 1 receptor.
Domazet Ivana; Holleran Brian J; Martin Stéphane S; Lavigne Pierre; Leduc Richard; Escher Emanuel; Guillemette Gaétan
The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gaétan Guillemette (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Domazet Ivana; Martin Stéphane S; Holleran Brian J; Morin Marie-Eve; Lacasse Patrick; Lavigne Pierre; Escher Emanuel; Leduc Richard; Guillemette Gaétan
The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.
The Journal of biological chemistry 2009;284(46):31953-61.
2009: Clément Martin; Cabana Jérôme; Holleran Brian J; Leduc Richard; Guillemette Gaétan; Lavigne Pierre; Escher Emanuel
Activation induces structural changes in the liganded angiotensin II type 1 receptor.
The Journal of biological chemistry 2009;284(39):26603-12.
2009: Domazet Ivana; Holleran Brian J; Martin Stéphane S; Lavigne Pierre; Leduc Richard; Escher Emanuel; Guillemette Gaétan
The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.
The Journal of biological chemistry 2009;284(18):11922-9.
2009: Nguyen Nathalie; Francoeur Nancy; Chartrand Valérie; Klarskov Klaus; Guillemette Gaétan; Boulay Guylain
Insulin promotes the association of heat shock protein 90 with the inositol 1,4,5-trisphosphate receptor to dampen its Ca2+ release activity.
Endocrinology 2009;150(5):2190-6.
2009: Holleran Brian J; Domazet Ivana; Beaulieu Marie-Eve; Yan Li Ping; Guillemette Gaétan; Lavigne Pierre; Escher Emanuel; Leduc Richard
Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
Biochemical pharmacology 2009;77(8):1374-82.
2009: Cuerrier Charles M; Benoit Martin; Guillemette Gaétan; Gobeil Fernand; Grandbois Michel
Real-time monitoring of angiotensin II-induced contractile response and cytoskeleton remodeling in individual cells by atomic force microscopy.
Pflügers Archiv : European journal of physiology 2009;457(6):1361-72.
2009: Béliveau Eric; Guillemette Gaétan
Microfilament and microtubule assembly is required for the propagation of inositol trisphosphate receptor-induced Ca2+ waves in bovine aortic endothelial cells.
Journal of cellular biochemistry 2009;106(2):344-52.
2009: Clément Martin; Guillemette Gaétan; Leduc Richard; Escher Emanuel
Structural changes in the binding pocket of the liganded angiotensin II receptor AT1 during activation.
Advances in experimental medicine and biology 2009;611():341-2.
2009: Arsenault J; Renaud M P La-Haye; Clément M; Fillion D; Guillemette G; Leduc R; Lavigne P; Escher E
Temperature-induced ligand contact point variations of the hAT1 receptor and of the constitutively active mutant N111G-hAT1.
Advances in experimental medicine and biology 2009;611():339-40.
2009: Fillion D; Guillemette G; Leduc R; Escher E
Photoprobe peptides to map the interactions of angiotensin II with its receptor AT1.
Advances in experimental medicine and biology 2009;611():329-30.
2008: Proulx Christophe D; Holleran Brian J; Boucard Antony A; Escher Emanuel; Guillemette Gaétan; Leduc Richard
Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.
Molecular pharmacology 2008;74(3):552-61.
2008: Proulx Christophe D; Holleran Brian J; Lavigne Pierre; Escher Emanuel; Guillemette Gaétan; Leduc Richard
Biological properties and functional determinants of the urotensin II receptor.
Peptides 2008;29(5):691-9.
2008: Leclerc Patrice C; Proulx Christophe D; Arguin Guillaume; Bélanger Simon; Gobeil Fernand; Escher Emanuel; Leduc Richard; Guillemette Gaétan
Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II.
American journal of hypertension 2008;21(1):67-71.
2007: Arsenault J; Renaud M P La Haye; Clément M; Fillion D; Guillemette G; Leduc R; Lavigne P; Escher E
Temperature-dependent variations of ligand-receptor contact points in hAT(1).
Journal of peptide science : an official publication of the European Peptide Society 2007;13(9):575-80.
2007: Caron Annabelle Z; Chaloux Benoit; Arguin Guillaume; Guillemette Gaetan
Protein kinase C decreases the apparent affinity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells.
Cell calcium 2007;42(3):323-31.
2007: Martin Stéphane S; Holleran Brian J; Escher Emanuel; Guillemette Gaétan; Leduc Richard
Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.
Molecular pharmacology 2007;72(1):182-90.
2007: Chaloux Benoit; Caron Annabelle Z; Guillemette Gaétan
Protein kinase A increases the binding affinity and the Ca2+ release activity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells.
Biology of the cell / under the auspices of the European Cell Biology Organization 2007;99(7):379-88.
2007: Regimbald-Dumas Yannik; Arguin Guillaume; Fregeau Marc-Olivier; Guillemette Gaétan
cAMP-dependent protein kinase enhances inositol 1,4,5-trisphosphate-induced Ca2+ release in AR4-2J cells.
Journal of cellular biochemistry 2007;101(3):609-18.
2007: Arguin Guillaume; Regimbald-Dumas Yannik; Fregeau Marc-Olivier; Caron Annabelle Z; Guillemette Gaetan
Protein kinase C phosphorylates the inositol 1,4,5-trisphosphate receptor type 2 and decreases the mobilization of Ca2+in pancreatoma AR4-2J cells.
The Journal of endocrinology 2007;192(3):659-68.
2006: Leclerc Patrice C; Lanctot Pascal M; Auger-Messier Mannix; Escher Emanuel; Leduc Richard; Guillemette Gaetan
S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.
British journal of pharmacology 2006;148(3):306-13.
2006: Lanctôt Pascal M; Leclerc Patrice C; Escher Emanuel; Guillemette Gaétan; Leduc Richard
Role of N-glycan-dependent quality control in the cell-surface expression of the AT1 receptor.
Biochemical and biophysical research communications 2006;340(2):395-402.
2006: Clément Martin; Chamberland Caroline; Pérodin Jacqueline; Leduc Richard; Guillemette Gaétan; Escher Emanuel
The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant.
Journal of receptor and signal transduction research 2006;26(5-6):417-33.
2005: Auger-Messier Mannix; Turgeon Eric S; Leduc Richard; Escher Emanuel; Guillemette Gaetan
The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells.
Experimental cell research 2005;308(1):188-95.
2005: Lanctot Pascal M; Leclerc Patrice C; Clément Martin; Auger-Messier Mannix; Escher Emanuel; Leduc Richard; Guillemette Gaétan
Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor.
The Biochemical journal 2005;390(Pt 1):367-76.
2005: Clément Martin; Martin Stéphane S; Beaulieu Marie-Eve; Chamberland Caroline; Lavigne Pierre; Leduc Richard; Guillemette Gaétan; Escher Emanuel
Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay.
The Journal of biological chemistry 2005;280(29):27121-9.
2005: Moris Marc-Antoine; Caron Annabelle Z; Guillemette Gaétan; Rognan Didier; Schmitt Martine; Schlewer Gilbert
Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
Journal of medicinal chemistry 2005;48(4):1251-5.
2005: Guillemette Joelle; Caron Annabelle Z; Regimbald-Dumas Yannik; Arguin Guillaume; Mignery Gregory A; Boulay Guylain; Guillemette Gaetan
Expression of a truncated form of inositol 1,4,5-trisphosphate receptor type III in the cytosol of DT40 triple inositol 1,4,5-trisphosphate receptor-knockout cells.
Cell calcium 2005;37(2):97-104.
2005: Proulx Christophe D; Simaan May; Escher Emanuel; Laporte Stéphane A; Guillemette Gaétan; Leduc Richard
Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization.
The Biochemical journal 2005;385(Pt 1):115-23.
2004: Martin Stéphane S; Boucard Antony A; Clément Martin; Escher Emanuel; Leduc Richard; Guillemette Gaétan
Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
The Journal of biological chemistry 2004;279(49):51415-23.
2004: Auger-Messier Mannix; Arguin Guillaume; Chaloux Benoit; Leduc Richard; Escher Emanuel; Guillemette Gaetan
Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.
Molecular endocrinology (Baltimore, Md.) 2004;18(12):2967-80.
2004: Moris Marc-Antoine; Caron Annabelle Z; Guillemette Gaétan; Schlewer Gilbert
Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate).
Bioorganic & medicinal chemistry 2004;12(15):3995-4001.
2003: Auger-Messier Mannix; Clement Martin; Lanctot Pascal M; Leclerc Patrice C; Leduc Richard; Escher Emanuel; Guillemette Gaetan
The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha.
Endocrinology 2003;144(12):5277-84.
2003: Boucard Antony A; Roy Marise; Beaulieu Marie-Eve; Lavigne Pierre; Escher Emanuel; Guillemette Gaetan; Leduc Richard
Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
The Journal of biological chemistry 2003;278(38):36628-36.
2003: Caron Annabelle Z; Arguin Guillaume; Guillemette Gaetan
Angiotensin IV interacts with a juxtamembrane site on AT(4)/IRAP suggesting an allosteric mechanism of enzyme modulation.
Regulatory peptides 2003;113(1-3):9-15.
2003: Boucard Antony A; Sauvé Simon S; Guillemette Gaétan; Escher Emanuel; Leduc Richard
Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
The Biochemical journal 2003;370(Pt 3):829-38.
2002: Pérodin Jacqueline; Deraët Maud; Auger-Messier Mannix; Boucard Antony A; Rihakova Lenka; Beaulieu Marie-Eve; Lavigne Pierre; Parent Jean-Luc; Guillemette Gaétan; Leduc Richard; Escher Emanuel
Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor.
Biochemistry 2002;41(48):14348-56.
2002: Leclerc Patrice C; Auger-Messier Mannix; Lanctot Pascal M; Escher Emanuel; Leduc Richard; Guillemette Gaétan
A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling.
Endocrinology 2002;143(12):4702-10.
2002: Deraët M; Rihakova L; Boucard A; Pèrodin J; Sauvé S; Mathieu A P; Guillemette G; Leduc R; Lavigne P; Escher E
Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form.
Canadian journal of physiology and pharmacology 2002;80(5):418-25.
2002: Rihakova Lenka; Deraët Maud; Auger-Messier Mannix; Pérodin Jacqueline; Boucard Antony A; Guillemette Gaétan; Leduc Richard; Lavigne Pierre; Escher Emanuel
Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction.
Journal of receptor and signal transduction research 2002;22(1-4):297-313.
2002: Laflamme Karina; Domingue Olivier; Guillemette Benoit I; Guillemette Gaétan
Immunohistochemical localization of type 2 inositol 1,4,5-trisphosphate receptor to the nucleus of different mammalian cells.
Journal of cellular biochemistry 2002;85(1):219-28.
2001: Poirier S N; Poitras M; Laflamme K; Guillemette G
Thiol-reactive agents biphasically regulate inositol 1,4,5-trisphosphate binding and Ca(2+) release activities in bovine adrenal cortex microsomes.
Endocrinology 2001;142(6):2614-21.
2001: Poirier S N; Poitras M; Chorvatova A; Payet M D; Guillemette G
FK506 blocks intracellular Ca2+ oscillations in bovine adrenal glomerulosa cells.
Biochemistry 2001;40(21):6486-92.
2001: Farmer P J; Bernier S G; Lepage A; Guillemette G; Regoli D; Sirois P
Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins.
American journal of physiology. Lung cellular and molecular physiology 2001;280(4):L732-8.
2001: Pelletier S; Dubé J; Villeneuve A; Gobeil F; Yang Q; Battistini B; Guillemette G; Sirois P
Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.
British journal of pharmacology 2001;132(5):999-1008.
2000: Boucard A A; Wilkes B C; Laporte S A; Escher E; Guillemette G; Leduc R
Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure.
Biochemistry 2000;39(32):9662-70.
2000: Gosselin M J; Leclerc P C; Auger-Messier M; Guillemette G; Escher E; Leduc R
Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding.
Biochimica et biophysica acta 2000;1497(1):94-102.
2000: Pelletier S; Dubé J; Villeneuve A; Gobeil F; Bernier S G; Battistini B; Guillemette G; Sirois P
Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors.
British journal of pharmacology 2000;129(2):243-50.
2000: Poitras M; Poirier S N; Laflamme K; Simoneau M; Escher E; Guillemette G
Different populations of inositol 1,4,5-trisphosphate receptors expressed in the bovine adrenal cortex.
Receptors & channels 2000;7(1):41-52.
1999: Briand S I; Neugebauer W; Guillemette G
Agonist-dependent AT(4) receptor internalization in bovine aortic endothelial cells.
Journal of cellular biochemistry 1999;75(4):587-97.
1999: Ballereau S; Guédat P; Poirier S N; Guillemette G; Spiess B; Schlewer G
Synthesis, acid-base behavior, and binding properties of 6-modified myo-inositol 1,4,5-tris(phosphate)s.
Journal of medicinal chemistry 1999;42(23):4824-35.
1999: Lanctôt P M; Leclerc P C; Escher E; Leduc R; Guillemette G
Role of N-glycosylation in the expression and functional properties of human AT1 receptor.
Biochemistry 1999;38(27):8621-7.
1999: Laporte S A; Boucard A A; Servant G; Guillemette G; Leduc R; Escher E
Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.
Molecular endocrinology (Baltimore, Md.) 1999;13(4):578-86.
1999: Chrétien L; Laporte S A; Escher E; Leduc R; Guillemette G
The bradykinin B2 receptor couples less efficiently than the angiotensin AT1 receptor to the G protein Gq in transiently transfected COS-7 cells.
Receptors & channels 1999;6(6):425-33.
1998: Briand S I; Bellemare J M; Bernier S G; Guillemette G
Study on the functionality and molecular properties of the AT4 receptor.
Endocrine research 1998;24(3-4):315-23.
1998: Chrétien L; Richard D E; Poirier S N; Poitras M; Guillemette G
Bovine adrenal glomerulosa cells express such a low level of functional B2 receptors that bradykinin does not significantly increase their aldosterone production.
The Journal of endocrinology 1998;156(3):449-60.
1998: Bernier S G; Bellemare J M; Escher E; Guillemette G
Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV.
Biochemistry 1998;37(12):4280-7.
1998: Bouley R; Pérodin J; Plante H; Rihakova L; Bernier S G; Maletínská L; Guillemette G; Escher E
N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor.
European journal of pharmacology 1998;343(2-3):323-31.
1998: Servant G; Escher E; Guillemette G
The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors.
Regulatory peptides 1998;73(1):35-41.
1998: Briand S I; Bernier S G; Guillemette G
Monitoring of phospholipase A2 activation in cultured cells using tritiated arachidonic acid.
Methods in molecular biology (Clifton, N.J.) 1998;105():161-6.
1998: Poitras M; Sidibé A; Richard D E; Chrétien L; Guillemette G
Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II.
Receptors & channels 1998;6(1):65-72.
1998: Laporte S A; Roy S F; Escher E; Guillemette G; Leduc R
Essential role of leucine222 in mediating signal transduction of the human angiotensin II type 1 receptor.
Receptors & channels 1998;5(2):103-12.
1997: Richard D E; Laporte S A; Bernier S G; Leduc R; Guillemette G
Desensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells.
Endocrinology 1997;138(9):3828-35.
1997: Chrétien L; Laporte S A; Escher E; Leduc R; Guillemette G
Use of LiCl in phospholipase C assays masks the impaired functionality of a mutant angiotensin II receptor.
Cellular signalling 1997;9(5):379-82.
1997: Roy S F; Laporte S A; Escher E; Leduc R; Guillemette G
Epitope tagging and immunoreactivity of the human angiotensin II type 1 receptor.
Canadian journal of physiology and pharmacology 1997;75(6):690-5.
1997: Bouley R; Gosselin M; Plante H; Servant G; Pérodin J; Arcand M; Guillemette G; Escher E
Characterization of a specific binding site for angiotensin II in chicken liver.
Canadian journal of physiology and pharmacology 1997;75(6):568-75.
1997: Richard D E; Chrétien L; Caron M; Guillemette G
Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway.
Molecular and cellular endocrinology 1997;129(2):209-18.
1997: Servant G; Laporte S A; Leduc R; Escher E; Guillemette G
Identification of angiotensin II-binding domains in the rat AT2 receptor with photolabile angiotensin analogs.
The Journal of biological chemistry 1997;272(13):8653-9.
1997: Dumitriu D; Prié S; Bernier S G; Guillemette G; Sirois P
Mechanism of action of leukotriene D4 on guinea pig tracheal smooth muscle cells: roles of Ca++ influx and intracellular Ca++ release.
The Journal of pharmacology and experimental therapeutics 1997;280(3):1357-65.
1996: Briand S I; Bernier S G; Guillemette G
Calcium-calmodulin plays a major role in bradykinin-induced arachidonic acid release by bovine aortic endothelial cells.
Journal of cellular biochemistry 1996;63(3):292-301.
1996: Laporte S A; Servant G; Richard D E; Escher E; Guillemette G; Leduc R
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
Molecular pharmacology 1996;49(1):89-95.
1996: Servant G; Dudley D T; Escher E; Guillemette G
Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells.
The Biochemical journal 1996;313 ( Pt 1)():297-304.
1995: Bernier S G; Servant G; Boudreau M; Fournier A; Guillemette G
Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells.
European journal of pharmacology 1995;291(2):191-200.
1995: Prié S; Guillemette G; Boulay G; Borgeat P; Sirois P
Leukotriene C4 receptors on guinea pig tracheocytes.
The Journal of pharmacology and experimental therapeutics 1995;275(1):312-8.
1995: Poitras M; Ribeiro-Do-Valle R M; Poirier S N; Guillemette G
Bidirectional activity of the endoplasmic reticulum Ca(2+)-ATPase of bovine adrenal cortex.
Biochemistry 1995;34(30):9755-61.
1995: Servant M; Guillemette G; Morisset J
Pancreatic acinar-cell desensitization alters InsP3 production and Ca2+ mobilization under conditions where InsP3 receptor remains intact.
The Biochemical journal 1995;305 ( Pt 1)():103-10.
1994: Bernier S G; Fournier A; Guillemette G
A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes.
European journal of pharmacology 1994;271(1):55-63.
1994: Boulay G; Chrétien L; Richard D E; Guillemette G
Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state.
Endocrinology 1994;135(5):2130-6.
1994: Servant M; Guillemette G; Morisset J
Pharmacologic characterization of the inositol trisphosphate receptor in rat pancreas.
Pancreas 1994;9(5):591-8.
1994: Servant G; Dudley D T; Escher E; Guillemette G
The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.
Molecular pharmacology 1994;45(6):1112-8.
1994: Chrétien L; Guillemette G; Regoli D
Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain.
European journal of pharmacology 1994;256(1):73-8.
1994: Richard D E; Bernier S; Boulay G; Guillemette G
Selective interaction of chemical dyes with inositol 1,4,5-trisphosphate recognition sites.
Canadian journal of physiology and pharmacology 1994;72(2):174-81.
1994: Ribeiro-do-Valle R M; Poitras M; Boulay G; Guillemette G
The important discrepancy between the apparent affinity observed in Ca2+ mobilization studies and the Kd measured in binding studies is a consequence of the quantal process by which inositol 1,4,5-trisphosphate releases Ca2+ from bovine adrenal cortex microsomes.
Cell calcium 1994;15(1):79-88.
1993: Poitras M; Bernier S; Servant M; Richard D E; Boulay G; Guillemette G
The high affinity state of inositol 1,4,5-trisphosphate receptor is a functional state.
The Journal of biological chemistry 1993;268(32):24078-82.
1993: Servant G; Boulay G; Bossé R; Escher E; Guillemette G
Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium.
Molecular pharmacology 1993;43(5):677-83.
1993: Bossé R; Servant G; Zhou L M; Boulay G; Guillemette G; Escher E
Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor.
Regulatory peptides 1993;44(2):215-23.
1993: Bernier S; Guillemette G
Increased inositol 1,4,5-trisphosphate binding capacity in vascular smooth muscle of spontaneously hypertensive rats.
American journal of hypertension 1993;6(3 Pt 1):217-25.
1993: Poitras M; Bernier S; Boulay G; Fournier A; Guillemette G
Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes.
European journal of pharmacology 1993;244(3):203-10.
1992: Tousignant C; Chrétien L; Guillemette G; Regoli D
Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist.
Brain research 1992;596(1-2):243-50.
1992: Boulay G; Servant G; Luong T T; Escher E; Guillemette G
Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
Molecular pharmacology 1992;41(4):809-15.
1992: Luong T T; Boulay G; Guillemette G
Study on the stereoselectivity of inositol 1,4,5-trisphosphate recognition sites of bovine adrenal cortex.
Canadian journal of physiology and pharmacology 1992;70(4):434-41.
1992: Tousignant C; Regoli D; Rhaleb N E; Jukic D; Guillemette G
Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
European journal of pharmacology 1992;225(3):235-44.
1992: Tousignant C; Regoli D; Rhaleb N E; Jukic D; Guillemette G
125I-Tyr,D-Arg[Hyp3,D-Phe7,Leu8]BK, a radiolabelled B2 antagonist specifically interacts with two distinct binding sites on epithelial membranes of guinea pig ileum.
Agents and actions. Supplements 1992;38 ( Pt 1)():526-39.
1991: de Brum-Fernandes A J; Guillemette G; Borgeat P; Sirois P
Specific binding sites for leukotriene B4 in guinea pig brain membranes.
The Journal of pharmacology and experimental therapeutics 1991;259(3):1035-42.
1991: Luong T T; Poitras M; Boulay G; Guillemette G
Interaction of polyanions with the recognition sites for inositol 1,4,5-trisphosphate in the bovine adrenal cortex.
European journal of pharmacology 1991;208(3):213-21.
1991: Tousignant C; Guillemette G; Regoli D
Binding sites for [3H][Sar9, Met(O2)11]substance P in rat brain and guinea pig ileum.
Brain research 1991;560(1-2):1-11.
1991: Tousignant C; Guillemette G; Barabé J; Rhaleb N E; Regoli D
Characterization of kinin binding sites: identity of B2 receptors in the epithelium and the smooth muscle of the guinea pig ileum.
Canadian journal of physiology and pharmacology 1991;69(6):818-25.
1991: Guillemette G; Poitras M; Boulay G
Two Ca2+ transport systems are distinguished on the basis of their Mg2+ dependency in a post-nuclear particulate fraction of bovine adrenal cortex.
Cell calcium 1991;12(1):51-60.
1990: Guillemette G; Favreau I; Boulay G; Potier M
Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
Molecular pharmacology 1990;38(6):841-7.
1990: de Brum-Fernandes A J; Guillemette G; Sirois P
Leukotriene B4 binding sites in guinea-pig alveolar macrophages.
Prostaglandins 1990;40(5):515-27.
1990: Boulay G; Gallo-Payet N; Guillemette G
Implication of phospholipase C in the steroidogenic action of angiotensin II.
European journal of pharmacology 1990;189(4-5):267-75.
1990: Tousignant C; Guillemette G; Drapeau G; Télémaque S; Dion S; Regoli D
125I-BH[Sar9, Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system.
Brain research 1990;524(2):263-70.
1990: Guillemette G; Favreau I; Lamontagne S; Boulay G
2,3-Diphosphoglycerate is a nonselective inhibitor of inositol 1,4,5-trisphosphate action and metabolism.
European journal of pharmacology 1990;188(4-5):251-60.
1989: Tousignant C; Guillemette G; Drapeau G; Regoli D
Comparison of binding assay and biological activity on a NK-1 system with new selective agonists.
Neuropeptides 1989;14(4):275-83.
1989: Guillemette G; Boulay G; Gagnon S; Bosse R; Escher E
The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action.
The Biochemical journal 1989;261(1):309.
1989: Guillemette G; Lamontagne S; Boulay G; Mouillac B
Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
Molecular pharmacology 1989;35(3):339-44.
1988: Guillemette G; Segui J A
Effects of pH, reducing and alkylating reagents on the binding and Ca2+ release activities of inositol 1,4,5-triphosphate in the bovine adrenal cortex.
Molecular endocrinology (Baltimore, Md.) 1988;2(12):1249-55.

Sign-in to see more